🇺🇸 FDA
Patent

US 9408820

Broncholytic drug on the basis of prostaglandin

granted A61KA61K31/20A61K31/21

Quick answer

US patent 9408820 (Broncholytic drug on the basis of prostaglandin) held by OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOST'YU “NOXI LAB” expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOST'YU “NOXI LAB”
Grant date
Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/20, A61K31/21, A61P, A61P11/00